Thyroid carcinoma may recruit cytoplasmic hnRNPD to disturb the stability of mRNAs encoding cyclin-dependent kinase inhibitors, leading to uncontrolled growth and progression of tumor cells [44]. The gene discussed is HNRNPD; the disease is thyroid gland carcinoma.